Vasostatin-Apo2L, a preclinical product being developed by company’s Shanghai Qiaer subsidiary, is a recombinant fusion protein that integrates the function of extracted fragments of vasostatin, an inhibitor of
The study, Stealth C-3, is designed to evaluate the safety and efficacy of nitazoxanide in combination with (Pegasys, Roche) and ribavirin (Copegus, Roche) in treatment naive patients with
The newly allowed Vnus patent application contains claims that recite methods of applying energy from an elongate member leading to occlusion of a vein, where the elongate member
VisEn will use the additional financing to further advance its proprietary fluorescence in vivo imaging product pipelines, and to expand its commercial applications and customer support of its
Studies conducted in the laboratories of Ian Frazer (University of Queensland, Australia) and John Schiller (National Cancer Institute, US) have demonstrated that SPL7013 is a potent inhibitor of
Estradiol or norethindrone acetate tablets are AB rated to Activella, a brand product marketed by Novo Nordisk, which is used as a treatment for moderate to severe vasomotor
These toxicity studies in mice were conducted by trypanosomiasis researchers at Makerere University in Uganda. The Makerere researchers reported that Upstream’s trypanosomiasis candidates were well tolerated by mice
After Mr McCook’s resignation, Vicki Hitzhusen, chief accounting officer of the company will serve as interim principal financial officer. The company intends to initiate a search for a
In his new role, Hayden will be responsible for leading WellPoint’s Medicaid business division which currently serves more than 2 million members in 14 states. Prior to joining
Key initial areas of anticipated collaboration include pursuit of new therapies for cancer and respiratory diseases by advancing experimental and computational sciences in drug safety assessment, drug disposition,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.